Bliss GVS Pharma Limited (BLISSGVS)
₹167.95
INR+8.24(+5.16%)
As of December 2, 2024 10:00:00 AMBliss GVS Pharma Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹156.84
High: ₹162.48
All time High
The highest price the stock has ever reached since being listed
₹7411.29
Price Change 1h
Price change in the last hour of trading
+₹4.59 +2.81%
Price Change 1d
Price change over the last trading day
+₹4.59 +2.81%
Price Change 1w
Price change over the last week of trading
+₹ +%
Bliss GVS Pharma Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
1326.49 Cr
About Bliss GVS Pharma Limited Share
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
831
CEO
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Investors Don't See Light At End Of Bliss GVS Pharma Limited's (NSE:BLISSGVS) Tunnel
- Bliss GVS Pharma Limited Appoints Nandkumar Kashinath Chodankar as Chairman of the Board
- Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
- Bliss GVS Pharma's Q2 FY25 financials show mixed performance, MarketsMOJO advises 'Hold' on stock
- These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Bliss GVS Pharma Limited Resource
FAQs
The current price of Bliss GVS Pharma Limited is INR 167.95 — it has changed by 2.81% in the past 24 hours. Watch Bliss GVS Pharma Limited's stock price performance more closely on the chart.
Bliss GVS Pharma Limited has a market capitalization of 13264892928 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bliss GVS Pharma Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Bliss GVS Pharma Limited stocks are traded under the ticker [object Object]
As of December 02, 2024, the company has 831 employees.